Scitop Bio-tech - Public Comps and Valuation Multiples

Scitop Bio-tech Overview

About Scitop Bio-tech

Beijing Scitop Bio-tech Co Ltd is engaged in production and sales of compound food additives, edible probiotic products and animal and plant micro-ecological preparations. The company engages in provision of biotechnology services, consulting, development, transfer; development and sale of stereotyped packaged food additives, compound food additives. Its products include Probio-M8 and Probio-M9.

Founded

2003

HQ

Employees

402

Website

scitop.cn

Sectors

Nutraceuticals & Cosmeceuticals
BioTech

Financials

LTM Revenue $42.5M

LTM EBITDA $14.9M

EV

$577M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Scitop Bio-tech Financials

As of September 2025, Scitop Bio-tech reported last 12-month revenue of $42.5M and EBITDA of $14.9M.

In the same period, Scitop Bio-tech generated $24.8M in LTM gross profit and $13.2M in net income.

See Scitop Bio-tech valuation multiples based on analyst estimates

Scitop Bio-tech P&L

In the most recent fiscal year, Scitop Bio-tech reported revenue of $42.5M and EBITDA of $19.0M.

Scitop Bio-tech expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Scitop Bio-tech valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$42.5M	XXX	$42.5M	XXX	XXX	XXX
Gross Profit	$24.8M	XXX	$24.7M	XXX	XXX	XXX
Gross Margin	58%	XXX	58%	XXX	XXX	XXX
EBITDA	$14.9M	XXX	$19.0M	XXX	XXX	XXX
EBITDA Margin	35%	XXX	45%	XXX	XXX	XXX
EBIT	$15.3M	XXX	$10.6M	XXX	XXX	XXX
EBIT Margin	36%	XXX	25%	XXX	XXX	XXX
Net Profit	$13.2M	XXX	$13.2M	XXX	XXX	XXX
Net Margin	31%	XXX	31%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Scitop Bio-tech including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $42.5M. EBITDA for the last twelve months was $14.9M. In the most recent fiscal year, Scitop Bio-tech achieved $42.5M in revenue and $19.0M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$42.5M	Analyst estimates available to subscribers	$42.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$24.8M	Analyst estimates available to subscribers	$24.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	58.4% gross margin	Analyst estimates available to subscribers	58.3% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$14.9M	Analyst estimates available to subscribers	$19.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	35.0% EBITDA margin	Analyst estimates available to subscribers	44.7% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$15.3M	Analyst estimates available to subscribers	$10.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	36.0% EBIT margin	Analyst estimates available to subscribers	25.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$13.2M	Analyst estimates available to subscribers	$13.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	31.2% net profit margin	Analyst estimates available to subscribers	31.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Scitop Bio-tech

This financial data table provides comprehensive performance metrics for Scitop Bio-tech, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Scitop Bio-tech generated $42.5M in revenue over the last twelve months.
The company achieved $14.9M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $24.8M.
Net income over the last twelve months reached $13.2M.

Fiscal Year Performance

In the most recent fiscal year, Scitop Bio-tech reported $42.5M in total revenue.
Fiscal year EBITDA was $19.0M.
The company maintained a gross profit margin of 58.3% in the most recent fiscal year.
EBITDA margin for the fiscal year was 44.7%.
Net profit margin reached 31.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Scitop Bio-tech. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Scitop Bio-tech Stock Performance

Scitop Bio-tech has current market cap of CNY 4.4B (or $614M), and EV of CNY 4.1B (or $577M).

Market Cap Evolution

Scitop Bio-tech Stock Data

As of October 17, 2025, Scitop Bio-tech's stock price is CNY 17 (or $2).

See Scitop Bio-tech trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$577M	$614M	XXX	XXX	XXX	XXX	$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Scitop Bio-tech Valuation Multiples

Scitop Bio-tech's trades at 13.6x EV/Revenue multiple, and 30.4x EV/EBITDA.

See valuation multiples for Scitop Bio-tech and 15K+ public comps

Scitop Bio-tech Financial Valuation Multiples

As of October 17, 2025, Scitop Bio-tech has market cap of $614M and EV of $577M.

Equity research analysts estimate Scitop Bio-tech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Scitop Bio-tech has a P/E ratio of 46.4x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$614M	XXX	$614M	XXX	XXX	XXX
EV (current)	$577M	XXX	$577M	XXX	XXX	XXX
EV/Revenue	13.6x	XXX	13.6x	XXX	XXX	XXX
EV/EBITDA	38.8x	XXX	30.4x	XXX	XXX	XXX
EV/EBIT	37.8x	XXX	54.5x	XXX	XXX	XXX
EV/Gross Profit	23.3x	XXX	n/a	XXX	XXX	XXX
P/E	46.4x	XXX	46.4x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-59.3x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Scitop Bio-tech Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Scitop Bio-tech Margins & Growth Rates

Scitop Bio-tech's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $35K for the same period.

Scitop Bio-tech's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Scitop Bio-tech's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Scitop Bio-tech and other 15K+ public comps

Scitop Bio-tech Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	35%	XXX	45%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$35K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	8%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	12%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	33%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial